ESPR stock news
This page provides real-time market news, earnings updates, and company announcements related to Esperion Therapeutics, Inc. (ESPR).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-18 04:34 EST
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL (bempedoic acid) & NEXLIZET (bempedoic acid & ezetimibe) Prior to April 19, 2040
Finviz2026-02-17 13:03:12
Esperion Therapeutics (ESPR) has signed a settlement agreement with a fifth generic drug applicant.
老虎证券2026-02-17 13:18:02
ESPR stock chart
ESPR stock detailsESPR stock price change
On the last trading day, ESPR stock closed at 3.44 USD, with a price change of 1.18% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more